Cargando…
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
PURPOSE: To provide a feasible solution to the problem of failed glaucoma surgery. The aim was to evaluate the efficacy and safety of the additional effects of a combined surgical approach. This approach augments the application of trabeculectomy with mitomycin C (MMC) by adding subconjunctival beva...
Autores principales: | Saeed, Ahmed M, AboulNasr, Tarek Tawfeek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168860/ https://www.ncbi.nlm.nih.gov/pubmed/25246758 http://dx.doi.org/10.2147/OPTH.S67730 |
Ejemplares similares
-
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011) -
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
por: Mostafaei, Ali
Publicado: (2011) -
Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy
por: Zarei, Reza, et al.
Publicado: (2016) -
Comparison of Subconjunctival Mitomycin C and 5-Fluorouracil Injection for Needle Revision of Early Failed Trabeculectomy Blebs
por: Liu, Wei, et al.
Publicado: (2016) -
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010)